This inventor holds 2 USPTO granted patents. Top assignees: Queen's University at Kingston, Oregon Health & Science University. Active years: 2006-2008.
Company Filing History:
2 out of 423 
1 out of 524 
Years Active: 2006-2008
Title: Richard Oko: Innovator in Fertility Research
Introduction
Richard Oko is a notable inventor based in Kingston, Canada. He has made significant contributions to the field of fertility research, holding 2 patents that focus on enhancing reproductive health. His work has implications for both fertility enhancement and contraception.
Latest Patents
Oko's latest patents include the PT32 sperm protein and its interaction with the tyrosine kinase c-Yes. The perinuclear theca 32 (PT32) protein is disclosed as a key component that interacts with c-Yes. These innovations can be utilized in methods for enhancing fertility, diagnosing diminished fertility, and addressing abnormal spermiogenesis. Additionally, they provide avenues for contraception and the identification of fertility-enhancing agents. Transgenic, non-human animals are also part of his research disclosures.
Career Highlights
Throughout his career, Richard Oko has worked at prestigious institutions such as Queen's University at Kingston and Oregon Health & Science University. His research has been pivotal in advancing our understanding of reproductive biology and fertility treatments.
Collaborations
Oko has collaborated with various professionals in his field, including Peter Sutovsky, enhancing the impact of his research through shared expertise.
Conclusion
Richard Oko's innovative work in fertility research exemplifies the importance of scientific inquiry in addressing reproductive health challenges. His patents and collaborations continue to influence the field significantly.